PURE Bioscience (OTCMKTS:PURE) Stock Passes Above Two Hundred Day Moving Average – What’s Next?

PURE Bioscience (OTCMKTS:PURE) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.06 and traded as high as $0.0901. PURE Bioscience shares last traded at $0.0901, with a volume of 3,315 shares changing hands.

PURE Bioscience Stock Up 0.1%

The company has a market capitalization of $10.08 million, a P/E ratio of -3.00 and a beta of 0.25. The business has a fifty day moving average price of $0.06 and a 200 day moving average price of $0.06.

PURE Bioscience (OTCMKTS:PURE) last posted its quarterly earnings data on Monday, March 16th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.44 million during the quarter.

About PURE Bioscience

PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.

PURE’s product suite includes concentrate formulations and ready-to-use solutions.